Study of Noni in Cancer Patients
Neoplasms, Neoplasm Metastasis
About this trial
This is an interventional treatment trial for Neoplasms focused on measuring Advanced Cancer
Eligibility Criteria
Patients must: Have a pathologically or cytologically verified diagnosis of cancer and evidence of disease for which no standard treatment is available; Be ambulatory, capable of self care, and up and about more than 50% of waking hours; Have completed all other cancer treatments at least four weeks previously; Have been on any medications considered by their physician to be essential to their health (e.g. lipid lowering, antidiabetic , antihypertensive) at consistent dosing at least four weeks prior to starting noni; Agree to take no other CAM treatments while taking noni and agree to keep a diary, recording all medications taken daily, including all non prescription products and to record the time that noni is taken.
Sites / Locations
- University of Hawaii, Cancer Research Center